logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    
The biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and mid-cap biotechs will move shares higher during the summer and especially in the fall. In this interview with The Life…
Read more...
Sage Therapeutics ($SAGE) is a biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system, or CNS, disorders, where there are inadequate or no approved existing therapies. It is headquartered in Cambridge, MA, Eleven other companies are scheduled for the week of July 14,…
Read more...
Pfenex ($PFNX) was a December 2009 spinout from The Dow Chemical Company (DOW) headquartered in San Diego, CA, Eleven other companies are scheduled for the week of July 14, 2014. The full IPO calendar is available at IPOpremium. The manager and co-managers are William Blair and JMP Securities. The joint manager…
Read more...
Hospital operator HCA Holdings Inc. (HCA) is up 10.4% Tuesday to $61.37 per share on Wednesday, July 16, after the hospital pre-announced stronger than expected 2014 second-quarter results.  HCA posted $1.07 EPS at estimated $9.23 billion revenue, beating an estimate in a Thomson Reuters poll of analysts' of 91 cents per…
Read more...
Roka Bioscience ($ROKA) is a molecular diagnostics company initially focused on providing advanced testing solutions for the detection of foodborne pathogens headquartered in Warren, N.J. Eleven other companies are scheduled for the week of July 14, 2014. The full IPO calendar is available at IPOpremium. The manager and co-managers are BofA…
Read more...
CareDx ($CDNA) is a commercial stage company that develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients. It is headquartered in Brisbane, CA. Eleven other companies are scheduled for the week of July 14, 2014. The full IPO calendar is available at IPOpremium. The manager and co-managers are…
Read more...
After failing to ink a deal to acquire Swedish drug maker Meda in April, generic pharmaceutical company Mylan, Inc. (MYL) got its way to move its headquarters overseas, a move called a “tax inversion,” by striking an agreement with Abbott (ABT) on Monday.  Per the deal, Mylan will acquire Abbott’s…
Read more...
Equities.com invites you to watch Legalized: Making Sense of the Marijuana Green Rush our ground-breaking roundtable discussion on the impact of recreational marijuana's legalization in the United States. Our amazing panel of leading experts offer incredible insights from their perspectives of the regulatory, legislative, medical and business aspects of the industry. Click here…
Read more...
Early-stage biotech is a risky investment, but some bets are safer than others. Inovio Pharmaceuticals Inc. is doing high-stakes experimental work in both preventive and therapeutic medicine, addressing HIV, cancers and pre-cancers. The company's lead clinical program is in Phase 2 and a data readout is imminent, which has made…
Read more...
A rather interesting shockwave came across the newsfeeds this week. I was actually doing a TV interview when the host announced that GDP was down 2.9% for the first quarter. There was not much else I could do but note that that was a really bad, ugly, terrible, not very…
Read more...
Forecasting when we'll have a cure for cancer remains beyond the predictive powers of researchers and investors. But forecasting the focus of the latest American Society of Clinical Oncology meeting was in the cards: Immuno-oncology took center stage. In this interview with The Life Sciences Report, Medical Technology Stock Newsletter editor…
Read more...
GlobeImmune  (GBIM)  is a biopharmaceutical company established in 1995 focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen® platform. It is headquartered in Louisville, CO. Fourteen other companies are scheduled for the week of June 23, 2014. The complete IPO calendar is…
Read more...
Page 1 of 43

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.